SymbioPharm GmbH manufactures finished pharmaceuticals and dietary supplements and markets brands such as Symbioflor 1, Symbioflor 2 and Symbiolact. Since February 2024 the company has sold its own produced products predominantly to its parent and sole distributor Klinge Pharma, which has progressively taken over marketing and sales activities. The company’s scope also includes microbial cultures, body- and beauty-care products and plant protection agents; additionally it receives license fees from product sales to Klinge Pharma. In fiscal year 2024 SymbioPharm concentrated on a smaller set of core products, reported R&D expenses of TEUR 513 for clinical studies and outsourced its sales functions.
Gegenstand des Unternehmens ist die Herstellung und der Vertrieb von Fertigarzneimitteln und pharmazeutischen Präparaten, mikrobiellen Kulturen, Mitteln zur Körper- und Schönheitspflege, Pflanzenschutz- und Bodenverbesserungsmitteln sowie Herstellung und Vertrieb zugehöriger Druckschriften und Datenträger.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Wetzlar Local Court, HRB 4237 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) Wetzlar Local Court, HRB 4237 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) Wetzlar Local Court, HRB 4237 (as of 9 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Wetzlar Local Court, HRB 4237 (as of 9 October 2026)
BAG Diagnostics GmbH
Lich · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Gedeon Richter Pharma GmbH
Eschborn · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Laborgemeinschaft für Hämatologie und Onkologie GmbH LGHO GmbH
Leipzig · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
